ATEZOLIZUMAB

ATEZOLIZUMAB was reported 39719 times

ATEZOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYSTEMIC IMMUNE ACTIVATION 26 0.4906
1 MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA 22 0.4889
2 PHARYNGEAL NECROSIS 13 0.2826
3 ALPHA 1 FOETOPROTEIN DECREASED 11 0.2750
4 PARANEOPLASTIC NEUROLOGICAL SYNDROME 35 0.2734
5 REACTIVE CAPILLARY ENDOTHELIAL PROLIFERATION 15 0.2727
6 TUMOUR FISTULISATION 12 0.2000
7 SMALL CELL LUNG CANCER RECURRENT 11 0.1930
8 ENDOCRINE TOXICITY 19 0.1863
9 TUMOUR THROMBOSIS 38 0.1667
10 BLEEDING VARICOSE VEIN 70 0.1294
11 LIVER CARCINOMA RUPTURED 32 0.1270
12 TUMOUR HYPERPROGRESSION 31 0.1250
13 IMMUNE-MEDIATED ENCEPHALITIS 63 0.1191
14 VARICOSE VEIN RUPTURED 38 0.1184
15 HEPATOCELLULAR CARCINOMA 826 0.1085
16 TUMOUR INFLAMMATION 12 0.1071
17 OESOPHAGEAL VARICES HAEMORRHAGE 228 0.1049
18 SMALL CELL LUNG CANCER EXTENSIVE STAGE 12 0.1043
19 TUMOUR RUPTURE 58 0.1032
20 IMMUNE-MEDIATED HEPATITIS 199 0.0974
21 AUTOIMMUNE NEPHRITIS 19 0.0864
22 HEPATIC RUPTURE 19 0.0848
23 ALPHA 1 FOETOPROTEIN INCREASED 60 0.0843
24 SKIN CANDIDA 40 0.0766
25 MALIGNANT NEOPLASM OLIGOPROGRESSION 15 0.0754
26 HYPOPHYSITIS 151 0.0750
27 IMMUNE-MEDIATED NEUROPATHY 11 0.0710
28 THROMBOPHLEBITIS MIGRANS 24 0.0706
29 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 61 0.0695
30 LIMBIC ENCEPHALITIS 19 0.0688
31 TRIPLE NEGATIVE BREAST CANCER 45 0.0669
32 TUMOUR HAEMORRHAGE 187 0.0655
33 GASTRIC VARICES HAEMORRHAGE 21 0.0640
34 AUTOIMMUNE COLITIS 40 0.0620
35 ENCEPHALITIS AUTOIMMUNE 81 0.0616
36 NEPHRITIS 204 0.0610
37 INFECTED NEOPLASM 15 0.0602
38 FULMINANT TYPE 1 DIABETES MELLITUS 62 0.0601
39 IMMUNE-MEDIATED PNEUMONITIS 14 0.0598
40 SMALL CELL LUNG CANCER 90 0.0596
41 IMMUNE-MEDIATED LUNG DISEASE 108 0.0592
42 LYMPHOCYTIC HYPOPHYSITIS 16 0.0580
43 IMMUNE-MEDIATED ENTEROCOLITIS 203 0.0551
44 VARICES OESOPHAGEAL 155 0.0512
45 HAEMOBILIA 21 0.0506
46 SPONTANEOUS BACTERIAL PERITONITIS 12 0.0492
47 ADRENAL INSUFFICIENCY 594 0.0489
48 HYPOPITUITARISM 84 0.0482
49 IMMUNE-MEDIATED PANCREATITIS 18 0.0472
50 TUMOUR PERFORATION 15 0.0472
51 AUTOIMMUNE HYPOTHYROIDISM 11 0.0462
52 ENDOCRINE DISORDER 59 0.0460
53 PRIMARY ADRENAL INSUFFICIENCY 14 0.0459
54 THYROIDITIS 137 0.0456
55 TUMOUR NECROSIS 48 0.0454
56 LYMPHOMA TRANSFORMATION 16 0.0444
57 RADIATION NECROSIS 25 0.0436
58 IMMUNE-MEDIATED ADVERSE REACTION 67 0.0436
59 HEPATOBILIARY DISEASE 27 0.0431
60 IMMUNE-MEDIATED THYROIDITIS 21 0.0425
61 GASTRIC VARICES 20 0.0425
62 DEVICE RELATED BACTERAEMIA 13 0.0419
63 BLOOD CORTICOTROPHIN INCREASED 12 0.0415
64 PORTAL HYPERTENSIVE GASTROPATHY 23 0.0408
65 PROTEINURIA 756 0.0397
66 ENCEPHALITIS 275 0.0397
67 IMMUNE-MEDIATED ARTHRITIS 15 0.0394
68 BILIARY TRACT INFECTION 24 0.0386
69 MYOCARDITIS 442 0.0385
70 IMMUNE-MEDIATED MYOCARDITIS 62 0.0384
71 MYASTHENIC SYNDROME 29 0.0375
72 METASTASES TO ADRENALS 34 0.0368
73 GALLBLADDER RUPTURE 17 0.0367
74 PNEUMONITIS 995 0.0365
75 IMMUNE-MEDIATED CHOLANGITIS 13 0.0362
76 RADIATION PNEUMONITIS 76 0.0355
77 HYPOTHYROIDISM 1132 0.0354
78 NON-SMALL CELL LUNG CANCER METASTATIC 31 0.0353
79 PORTAL VEIN THROMBOSIS 114 0.0353
80 MYOSITIS 310 0.0345
81 IMMUNE-MEDIATED NEPHRITIS 16 0.0341
82 HYPERTHYROIDISM 488 0.0337
83 TUMOUR PSEUDOPROGRESSION 35 0.0320
84 AUTOIMMUNE MYOSITIS 15 0.0318
85 IMMUNE-MEDIATED RENAL DISORDER 13 0.0314
86 MESENTERIC VEIN THROMBOSIS 31 0.0311
87 TYPE 1 DIABETES MELLITUS 185 0.0307
88 INTESTINAL METASTASIS 11 0.0303
89 CORTISOL DECREASED 34 0.0297
90 ENTEROCOLITIS 171 0.0296
91 METASTASES TO MENINGES 67 0.0294
92 HEPATIC HAEMORRHAGE 25 0.0291
93 IMMUNE-MEDIATED DERMATITIS 29 0.0288
94 IMMUNE-MEDIATED HEPATIC DISORDER 56 0.0287
95 BLOOD CORTICOTROPHIN DECREASED 14 0.0287
96 CHOLANGITIS 178 0.0287
97 SECONDARY ADRENOCORTICAL INSUFFICIENCY 42 0.0278
98 TUMOUR ASSOCIATED FEVER 11 0.0269
99 CHOLANGITIS SCLEROSING 55 0.0268
100 NON-SMALL CELL LUNG CANCER 127 0.0265
101 HYPERAMYLASAEMIA 14 0.0257
102 CHOLANGITIS ACUTE 19 0.0252
103 SUPERIOR VENA CAVA SYNDROME 15 0.0248
104 RETROPERITONEAL LYMPHADENOPATHY 13 0.0247
105 AUTOIMMUNE HAEMOLYTIC ANAEMIA 84 0.0245
106 ADRENAL DISORDER 47 0.0245
107 HEPATIC ENCEPHALOPATHY 228 0.0244
108 PERIPHERAL MOTOR NEUROPATHY 34 0.0243
109 SKIN TOXICITY 136 0.0240
110 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 19 0.0238
111 ENTEROCOLITIS INFECTIOUS 22 0.0238
112 FEBRILE INFECTION 28 0.0238
113 HAEMOPERITONEUM 19 0.0237
114 THERAPY PARTIAL RESPONDER 369 0.0236
115 DUODENAL PERFORATION 23 0.0234
116 PORTAL HYPERTENSION 72 0.0233
117 BLOOD ALBUMIN ABNORMAL 12 0.0230
118 NEUTROPENIC SEPSIS 164 0.0229
119 GUILLAIN-BARRE SYNDROME 111 0.0229
120 TERMINAL ILEITIS 14 0.0228
121 METASTASES TO CENTRAL NERVOUS SYSTEM 289 0.0224
122 INFECTIOUS PLEURAL EFFUSION 34 0.0223
123 AUTOIMMUNE HEPATITIS 154 0.0221
124 LUNG ADENOCARCINOMA 66 0.0219
125 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 14 0.0218
126 PERIPHERAL SENSORY NEUROPATHY 127 0.0217
127 ASCITES 637 0.0216
128 BILIARY OBSTRUCTION 28 0.0216
129 COLITIS 812 0.0214
130 LICHENOID KERATOSIS 48 0.0210
131 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 26 0.0209
132 PARANEOPLASTIC SYNDROME 14 0.0207
133 AMYLASE INCREASED 76 0.0206
134 LYMPHANGIOSIS CARCINOMATOSA 21 0.0202
135 BILE DUCT STENOSIS 24 0.0200
136 EMBOLISM 165 0.0198
137 TUMOUR PAIN 26 0.0197
138 IMMUNE THROMBOCYTOPENIA 90 0.0196
139 OEDEMATOUS PANCREATITIS 11 0.0196
140 HEPATITIS 491 0.0192
141 DISEASE PROGRESSION 2260 0.0191
142 METASTASES TO PLEURA 20 0.0191
143 SUSPECTED OFF LABEL USE 84 0.0186
144 GASTROINTESTINAL PERFORATION 76 0.0183
145 INTERCEPTED PRODUCT STORAGE ERROR 65 0.0182
146 MYASTHENIA GRAVIS 147 0.0182
147 MYOCARDIAL INJURY 20 0.0178
148 PROTEIN URINE 16 0.0177
149 GENE MUTATION 35 0.0177
150 INTERSTITIAL LUNG DISEASE 854 0.0176
151 EMBOLISM ARTERIAL 21 0.0175
152 VITILIGO 41 0.0175
153 CORNEAL PERFORATION 11 0.0174
154 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 127 0.0169
155 CYTOMEGALOVIRUS ENTEROCOLITIS 13 0.0169
156 IMMUNE-MEDIATED HYPOTHYROIDISM 19 0.0168
157 HEPATIC LESION 71 0.0164
158 POLYMYALGIA RHEUMATICA 51 0.0160
159 HAND DERMATITIS 11 0.0159
160 HYPOTHALAMO-PITUITARY DISORDER 23 0.0158
161 HEPATIC FAILURE 474 0.0157
162 HYPOALBUMINAEMIA 122 0.0157
163 IMMUNE-MEDIATED MYOSITIS 43 0.0156
164 NEUTROPHIL COUNT DECREASED 628 0.0154
165 HEPATIC FUNCTION ABNORMAL 573 0.0153
166 PULMONARY TOXICITY 106 0.0150
167 METASTATIC NEOPLASM 63 0.0146
168 FEBRILE NEUTROPENIA 968 0.0146
169 SUBILEUS 30 0.0144
170 SMALL INTESTINAL PERFORATION 27 0.0144
171 SEROUS RETINAL DETACHMENT 12 0.0143
172 DERMATOMYOSITIS 36 0.0142
173 CANCER PAIN 36 0.0141
174 METASTASIS 100 0.0140
175 HYPERBILIRUBINAEMIA 144 0.0139
176 PERFORATION 11 0.0136
177 HYPERTRANSAMINASAEMIA 95 0.0136
178 RECTAL ULCER 16 0.0136
179 MENINGITIS 90 0.0135
180 HYDROTHORAX 11 0.0133
181 CYTOKINE RELEASE SYNDROME 265 0.0132
182 TROPONIN I INCREASED 22 0.0132
183 GASTROINTESTINAL TOXICITY 63 0.0131
184 METASTASES TO LYMPH NODES 88 0.0130
185 BILIARY TRACT DISORDER 18 0.0130
186 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 23 0.0129
187 OESOPHAGEAL HAEMORRHAGE 17 0.0128
188 NEPHROTIC SYNDROME 88 0.0128
189 METASTASES TO LUNG 148 0.0128
190 FEBRILE BONE MARROW APLASIA 54 0.0127
191 BLOOD BILIRUBIN INCREASED 342 0.0126
192 HEPATIC INFECTION 16 0.0125
193 TUMOUR LYSIS SYNDROME 110 0.0125
194 HEPATORENAL SYNDROME 21 0.0124
195 ENTERITIS 79 0.0123
196 GASTRIC PERFORATION 33 0.0121
197 METASTASES TO BONE 196 0.0119
198 HEPATIC MASS 23 0.0119
199 LYMPHOCYTE COUNT DECREASED 211 0.0119
200 LUNG ABSCESS 25 0.0119
201 DILATED CARDIOMYOPATHY 12 0.0119
202 ERYTHEMA MULTIFORME 109 0.0117
203 RHEUMATIC DISORDER 22 0.0114
204 HYPOMAGNESAEMIA 158 0.0113
205 MALIGNANT PLEURAL EFFUSION 19 0.0113
206 PEMPHIGOID 85 0.0113
207 DEVICE RELATED THROMBOSIS 11 0.0112
208 MYELITIS 17 0.0110
209 OPPORTUNISTIC INFECTION 20 0.0108
210 LIVER ABSCESS 35 0.0108
211 MYOCARDIAL NECROSIS MARKER INCREASED 18 0.0107
212 MYELITIS TRANSVERSE 15 0.0106
213 AUTOIMMUNE THYROIDITIS 40 0.0106
214 LIVER TRANSPLANT REJECTION 19 0.0106
215 THYROID DISORDER 163 0.0106
216 PNEUMATOSIS INTESTINALIS 30 0.0105
217 LIPASE INCREASED 80 0.0104
218 ASPARTATE AMINOTRANSFERASE INCREASED 548 0.0103
219 NON-CARDIAC CHEST PAIN 32 0.0101
220 PROCTITIS 28 0.0100
221 LARGE INTESTINE PERFORATION 69 0.0099
222 INTERCEPTED MEDICATION ERROR 46 0.0099
223 LYMPHADENOPATHY MEDIASTINAL 19 0.0099
224 LUNG NEOPLASM 42 0.0098
225 ADENOCARCINOMA 22 0.0098
226 HEPATIC NEOPLASM 32 0.0098
227 DERMATITIS PSORIASIFORM 20 0.0098
228 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 37 0.0097
229 POLYARTHRITIS 51 0.0097
230 PERIPHERAL SENSORIMOTOR NEUROPATHY 12 0.0095
231 BILIARY DILATATION 14 0.0095
232 HYDRONEPHROSIS 71 0.0095
233 NEOPLASM 109 0.0095
234 ALANINE AMINOTRANSFERASE INCREASED 582 0.0095
235 TROPONIN T INCREASED 12 0.0095
236 DUODENAL ULCER HAEMORRHAGE 27 0.0094
237 OBSTRUCTION GASTRIC 12 0.0093
238 MYELOSUPPRESSION 336 0.0093
239 SOFT TISSUE INFECTION 17 0.0093
240 URINARY TRACT OBSTRUCTION 22 0.0093
241 IMMUNE SYSTEM DISORDER 120 0.0091
242 HEPATIC CIRRHOSIS 171 0.0091
243 JAUNDICE CHOLESTATIC 32 0.0090
244 LICHEN PLANUS 21 0.0090
245 METASTASES TO LIVER 159 0.0090
246 LIVER DISORDER 401 0.0090
247 TUBULOINTERSTITIAL NEPHRITIS 169 0.0090
248 MUCOSAL INFLAMMATION 234 0.0089
249 SMALL INTESTINAL HAEMORRHAGE 18 0.0089
250 AORTIC ARTERIOSCLEROSIS 23 0.0089
251 INTENTIONAL PRODUCT USE ISSUE 780 0.0089
252 INTRA-ABDOMINAL HAEMATOMA 11 0.0089
253 CYTOPENIA 108 0.0088
254 HEPATOTOXICITY 196 0.0088
255 FEMALE GENITAL TRACT FISTULA 15 0.0088
256 BLOOD THYROID STIMULATING HORMONE INCREASED 80 0.0087
257 PNEUMOPERITONEUM 16 0.0087
258 PYELONEPHRITIS 75 0.0086
259 BLOOD BILIRUBIN ABNORMAL 11 0.0086
260 TRANSAMINASES INCREASED 190 0.0085
261 PERFORMANCE STATUS DECREASED 39 0.0083
262 INVESTIGATION ABNORMAL 12 0.0083
263 RASH MACULO-PAPULAR 185 0.0083
264 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 242 0.0083
265 PULMONARY SEPSIS 12 0.0082
266 EMBOLISM VENOUS 25 0.0082
267 ABDOMINAL INFECTION 21 0.0082
268 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 191 0.0082
269 ERYSIPELAS 41 0.0082
270 PYELONEPHRITIS ACUTE 16 0.0082
271 CHOLESTATIC LIVER INJURY 18 0.0081
272 DUODENAL ULCER 57 0.0081
273 HEPATIC CYTOLYSIS 103 0.0081
274 SIALOADENITIS 11 0.0081
275 BLOOD ALBUMIN DECREASED 64 0.0081
276 PANCREATITIS CHRONIC 19 0.0080
277 ENCEPHALOPATHY 197 0.0080
278 BACTERAEMIA 94 0.0079
279 THROMBOCYTOPENIA 882 0.0079
280 PERIODONTAL DISEASE 11 0.0078
281 VENA CAVA THROMBOSIS 13 0.0078
282 HYPONATRAEMIA 440 0.0078
283 ALVEOLITIS 11 0.0078
284 HAEMATOTOXICITY 74 0.0078
285 DERMATITIS 163 0.0078
286 ADRENOCORTICAL INSUFFICIENCY ACUTE 15 0.0077
287 PNEUMOTHORAX 121 0.0076
288 HYPOKALAEMIA 350 0.0076
289 SYSTEMIC CANDIDA 19 0.0076
290 HAEMOPTYSIS 211 0.0076
291 METASTASES TO PERITONEUM 19 0.0075
292 VASCULAR PSEUDOANEURYSM 13 0.0075
293 ORGANISING PNEUMONIA 37 0.0075
294 NEOPLASM PROGRESSION 258 0.0074
295 CHOLANGIOCARCINOMA 11 0.0074
296 HYPOPROTEINAEMIA 14 0.0074
297 UPPER GASTROINTESTINAL HAEMORRHAGE 123 0.0073
298 ORAL FUNGAL INFECTION 20 0.0073
299 LUNG CANCER METASTATIC 21 0.0073
300 VASCULAR DEVICE INFECTION 33 0.0073
301 ANAEMIA 1387 0.0073
302 POLYNEUROPATHY 87 0.0073
303 ARTERIAL THROMBOSIS 14 0.0072
304 TROPONIN INCREASED 55 0.0072
305 PLATELET COUNT DECREASED 767 0.0072
306 EMPYEMA 14 0.0070
307 LYMPHADENITIS 17 0.0070
308 DISSEMINATED INTRAVASCULAR COAGULATION 98 0.0070
309 MENINGITIS ASEPTIC 31 0.0069
310 DRUG-INDUCED LIVER INJURY 216 0.0069
311 BREAST DISORDER 14 0.0069
312 OSTEOLYSIS 14 0.0068
313 METASTASES TO SPINE 23 0.0068
314 BRONCHOPULMONARY ASPERGILLOSIS 53 0.0068
315 DIVERTICULAR PERFORATION 14 0.0068
316 POLYMYOSITIS 12 0.0068
317 CAPILLARY LEAK SYNDROME 14 0.0068
318 NEUTROPENIC COLITIS 14 0.0068
319 PNEUMONIA BACTERIAL 62 0.0067
320 SARCOIDOSIS 32 0.0067
321 CARDIAC TAMPONADE 32 0.0067
322 HYPERCALCAEMIA 83 0.0067
323 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
324 CARCINOEMBRYONIC ANTIGEN INCREASED 13 0.0067
325 CUTANEOUS LUPUS ERYTHEMATOSUS 13 0.0067
326 PERIPHERAL ISCHAEMIA 27 0.0066
327 PNEUMONIA VIRAL 21 0.0066
328 CELL DEATH 13 0.0065
329 SMALL INTESTINAL OBSTRUCTION 80 0.0065
330 INTESTINAL PERFORATION 72 0.0064
331 NEUTROPENIA 864 0.0063
332 ABDOMINAL ABSCESS 28 0.0063
333 GASTROINTESTINAL ULCER 14 0.0063
334 CHOLECYSTITIS 75 0.0063
335 ILEUS PARALYTIC 28 0.0063
336 DERMATITIS ACNEIFORM 38 0.0062
337 OESOPHAGITIS 68 0.0062
338 STRESS CARDIOMYOPATHY 36 0.0062
339 HEPATIC CYST 21 0.0062
340 CARDIAC DYSFUNCTION 23 0.0062
341 BLOOD ALKALINE PHOSPHATASE INCREASED 153 0.0062
342 SHOCK HAEMORRHAGIC 50 0.0061
343 GLOMERULONEPHRITIS 15 0.0061
344 HYPERURICAEMIA 25 0.0061
345 PLEURAL EFFUSION 369 0.0061
346 THROMBOTIC MICROANGIOPATHY 59 0.0060
347 ATYPICAL PNEUMONIA 18 0.0060
348 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
349 COVID-19 PNEUMONIA 71 0.0060
350 PERICARDIAL EFFUSION 139 0.0060
351 PULMONARY HAEMORRHAGE 47 0.0060
352 PANCYTOPENIA 334 0.0060
353 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
354 ILEUS 73 0.0059
355 PHYSICAL DECONDITIONING 15 0.0058
356 VENOUS THROMBOSIS LIMB 12 0.0058
357 CHRONIC GASTRITIS 13 0.0058
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 163 0.0057
359 LIVER INJURY 141 0.0057
360 PLEURISY 34 0.0057
361 LUNG OPACITY 15 0.0057
362 HYPOPHOSPHATAEMIA 42 0.0057
363 CHOLESTASIS 109 0.0057
364 SEPTIC SHOCK 246 0.0056
365 SPINAL CORD COMPRESSION 22 0.0056
366 UROSEPSIS 52 0.0056
367 BICYTOPENIA 11 0.0056
368 CEREBRAL INFARCTION 137 0.0056
369 KERATITIS 17 0.0056
370 PROTEIN TOTAL DECREASED 21 0.0056
371 JAUNDICE 149 0.0055
372 APLASIA PURE RED CELL 19 0.0055
373 SKIN DISORDER 184 0.0055
374 HAEMOTHORAX 16 0.0055
375 APPENDICITIS PERFORATED 14 0.0055
376 EOSINOPHIL COUNT DECREASED 13 0.0055
377 STOMATITIS 331 0.0055
378 DERMATITIS BULLOUS 39 0.0054
379 ANAL ABSCESS 29 0.0054
380 LUNG CONSOLIDATION 15 0.0054
381 INFUSION RELATED REACTION 354 0.0053
382 HYPERGLYCAEMIA 194 0.0053
383 PATHOLOGICAL FRACTURE 27 0.0053
384 ACUTE CORONARY SYNDROME 44 0.0053
385 SEPSIS 587 0.0053
386 BLOOD CREATININE INCREASED 343 0.0052
387 PYREXIA 1803 0.0052
388 HYPOXIA 183 0.0052
389 THROMBOCYTOSIS 19 0.0052
390 RESPIRATORY TRACT INFECTION VIRAL 12 0.0051
391 LEUKOPENIA 257 0.0051
392 DIABETIC KETOACIDOSIS 123 0.0051
393 NEUROPATHY PERIPHERAL 484 0.0051
394 TENOSYNOVITIS 14 0.0051
395 DEATH 4361 0.0051
396 HEPATITIS FULMINANT 15 0.0051
397 HEPATITIS B REACTIVATION 16 0.0050
398 BILE DUCT STONE 16 0.0050
399 HEPATOCELLULAR INJURY 71 0.0050
400 RENAL TUBULAR DISORDER 14 0.0050
401 HAEMATEMESIS 126 0.0050
402 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 51 0.0050
403 PERICARDITIS 83 0.0049
404 ATRIOVENTRICULAR BLOCK COMPLETE 33 0.0049
405 DECREASED APPETITE 1143 0.0049
406 MELAENA 107 0.0049
407 ACUTE KIDNEY INJURY 743 0.0049
408 HYPERTENSION 1028 0.0048
409 NEUROLOGICAL DECOMPENSATION 11 0.0047
410 GAMMA-GLUTAMYLTRANSFERASE INCREASED 105 0.0047
411 NEOPLASM RECURRENCE 16 0.0047
412 HAEMORRHOIDAL HAEMORRHAGE 23 0.0047
413 STEVENS-JOHNSON SYNDROME 104 0.0047
414 MOUTH ULCERATION 98 0.0046
415 SUDDEN DEATH 49 0.0046
416 BLOOD THYROID STIMULATING HORMONE DECREASED 21 0.0046
417 FAILURE TO THRIVE 24 0.0046
418 LACUNAR INFARCTION 11 0.0046
419 FACIAL PARALYSIS 39 0.0046
420 DRUG ERUPTION 81 0.0046
421 RESPIRATORY FAILURE 332 0.0045
422 PANNICULITIS 11 0.0045
423 THROMBOTIC THROMBOCYTOPENIC PURPURA 16 0.0045
424 WHITE BLOOD CELL COUNT DECREASED 491 0.0045
425 AUTOIMMUNE DISORDER 44 0.0045
426 ATRIAL FLUTTER 36 0.0045
427 HICCUPS 37 0.0045
428 ANAL FISTULA 24 0.0045
429 ENDOCARDITIS 23 0.0045
430 ACUTE RESPIRATORY FAILURE 85 0.0044
431 BLOOD MAGNESIUM DECREASED 38 0.0044
432 HYPERAMMONAEMIA 22 0.0044
433 PUSTULAR PSORIASIS 15 0.0044
434 NEPHROPATHY TOXIC 49 0.0044
435 BLOOD CREATINE PHOSPHOKINASE INCREASED 125 0.0043
436 CEREBRAL DISORDER 32 0.0043
437 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0043
438 EJECTION FRACTION DECREASED 67 0.0043
439 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 41 0.0043
440 RETINOPATHY 16 0.0043
441 GENERAL PHYSICAL HEALTH DETERIORATION 496 0.0043
442 ANAL HAEMORRHAGE 12 0.0043
443 CACHEXIA 22 0.0043
444 PROSTATITIS 13 0.0043
445 CARDIOTOXICITY 38 0.0043
446 OFF LABEL USE 3721 0.0042
447 BLOOD DISORDER 34 0.0042
448 HEPATITIS TOXIC 11 0.0042
449 COMPARTMENT SYNDROME 11 0.0042
450 PROTEIN URINE PRESENT 21 0.0042
451 PNEUMOCYSTIS JIROVECII PNEUMONIA 42 0.0042
452 PANCREATITIS 221 0.0042
453 TOXIC SKIN ERUPTION 42 0.0042
454 CARDIAC FAILURE 334 0.0042
455 HYPERKALAEMIA 145 0.0041
456 C-REACTIVE PROTEIN INCREASED 149 0.0041
457 GASTRITIS EROSIVE 19 0.0041
458 CHOLECYSTITIS ACUTE 23 0.0041
459 HAEMATURIA 139 0.0041
460 RENAL IMPAIRMENT 341 0.0041
461 LOWER GASTROINTESTINAL HAEMORRHAGE 30 0.0041
462 HYPERPYREXIA 17 0.0040
463 INTESTINAL ISCHAEMIA 22 0.0040
464 MIXED LIVER INJURY 12 0.0040
465 PLEURITIC PAIN 11 0.0040
466 ISCHAEMIC STROKE 71 0.0040
467 BRONCHIOLITIS 14 0.0040
468 GASTRIC ULCER HAEMORRHAGE 22 0.0040
469 ALTERED STATE OF CONSCIOUSNESS 86 0.0040
470 CARDIAC FAILURE ACUTE 26 0.0039
471 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
472 LUNG DISORDER 190 0.0039
473 ELECTROLYTE IMBALANCE 45 0.0039
474 WOUND DEHISCENCE 13 0.0038
475 CUTANEOUS VASCULITIS 14 0.0038
476 HYPOCALCAEMIA 72 0.0038
477 BUNDLE BRANCH BLOCK LEFT 16 0.0038
478 HAEMORRHAGE INTRACRANIAL 56 0.0037
479 CYSTITIS HAEMORRHAGIC 15 0.0037
480 NEUROTOXICITY 65 0.0037
481 MYOPATHY 32 0.0037
482 HEPATITIS ACUTE 24 0.0037
483 SKIN REACTION 52 0.0037
484 NERVOUS SYSTEM DISORDER 115 0.0037
485 HAEMOLYTIC ANAEMIA 33 0.0037
486 PNEUMONIA ASPIRATION 92 0.0037
487 SPLENOMEGALY 43 0.0037
488 FIBRIN D DIMER INCREASED 13 0.0037
489 BRAIN OEDEMA 46 0.0036
490 PARONYCHIA 16 0.0036
491 CEREBRAL HAEMORRHAGE 130 0.0036
492 ANXIETY DISORDER 12 0.0036
493 COLITIS MICROSCOPIC 17 0.0036
494 DUODENITIS 11 0.0036
495 PNEUMONIA 1160 0.0036
496 SCLERODERMA 13 0.0036
497 BRAIN NATRIURETIC PEPTIDE INCREASED 11 0.0036
498 LYMPHADENOPATHY 126 0.0036
499 VENTRICULAR ARRHYTHMIA 13 0.0036
500 MALIGNANT NEOPLASM PROGRESSION 364 0.0036
501 OPTIC NEURITIS 32 0.0035
502 CEREBRAL ATROPHY 14 0.0035
503 PULMONARY EMBOLISM 333 0.0035
504 EPISTAXIS 262 0.0035
505 IRIDOCYCLITIS 11 0.0035
506 GASTRIC HAEMORRHAGE 40 0.0035
507 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
508 NEOPLASM MALIGNANT 230 0.0034
509 VASCULITIS 40 0.0034
510 DIVERTICULUM INTESTINAL 15 0.0034
511 CYTOMEGALOVIRUS INFECTION 57 0.0034
512 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
513 GASTRIC ULCER 65 0.0034
514 ANAPHYLACTIC SHOCK 88 0.0034
515 ACUTE PULMONARY OEDEMA 19 0.0034
516 BACTERIAL SEPSIS 11 0.0034
517 OESOPHAGEAL DISORDER 13 0.0034
518 FEMORAL NECK FRACTURE 17 0.0033
519 GASTROINTESTINAL HAEMORRHAGE 277 0.0033
520 VENOUS THROMBOSIS 13 0.0033
521 GINGIVAL BLEEDING 45 0.0033
522 RASH PUSTULAR 24 0.0033
523 PNEUMONIA FUNGAL 13 0.0033
524 VARICOSE VEIN 17 0.0033
525 PERITONITIS 68 0.0033
526 COLITIS ISCHAEMIC 22 0.0033
527 BREAST CANCER METASTATIC 35 0.0033
528 DEVICE RELATED INFECTION 50 0.0032
529 PANCREATIC DISORDER 16 0.0032
530 AGRANULOCYTOSIS 60 0.0032
531 LIVER FUNCTION TEST INCREASED 69 0.0032
532 ANGIOPATHY 18 0.0032
533 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
534 HEPATIC NECROSIS 12 0.0032
535 PURPURA 28 0.0032
536 PULMONARY MASS 47 0.0032
537 RETINAL DETACHMENT 29 0.0032
538 HEPATITIS B 19 0.0031
539 ACIDOSIS 24 0.0031
540 OEDEMA 170 0.0031
541 GASTRITIS 82 0.0031
542 HUMERUS FRACTURE 15 0.0031
543 ATELECTASIS 30 0.0031
544 UVEITIS 42 0.0031
545 ACUTE MYOCARDIAL INFARCTION 91 0.0031
546 CONSTIPATION 669 0.0031
547 APLASTIC ANAEMIA 16 0.0031
548 VULVOVAGINAL MYCOTIC INFECTION 12 0.0030
549 BONE LESION 11 0.0030
550 CARDIOMYOPATHY 45 0.0030
551 TOXIC EPIDERMAL NECROLYSIS 46 0.0030
552 LOCALISED OEDEMA 14 0.0030
553 GASTROENTERITIS 44 0.0030
554 HYPERTHERMIA 23 0.0030
555 NEUROLOGICAL SYMPTOM 17 0.0030
556 PULMONARY FIBROSIS 57 0.0030
557 SPINAL COMPRESSION FRACTURE 24 0.0029
558 LYMPHOPENIA 41 0.0029
559 INTERNAL HAEMORRHAGE 33 0.0029
560 ACUTE RESPIRATORY DISTRESS SYNDROME 51 0.0029
561 NECROSIS 16 0.0029
562 CORONAVIRUS INFECTION 19 0.0029
563 ODYNOPHAGIA 17 0.0028
564 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
565 SKIN ULCER 73 0.0028
566 NEUTROPHILIA 16 0.0028
567 HEPATIC PAIN 12 0.0028
568 LUNG NEOPLASM MALIGNANT 115 0.0028
569 LOWER RESPIRATORY TRACT INFECTION 127 0.0028
570 ACUTE HEPATIC FAILURE 38 0.0028
571 RESPIRATORY TRACT INFECTION 72 0.0028
572 LEUKOCYTOSIS 50 0.0028
573 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
574 BONE MARROW FAILURE 56 0.0028
575 GENERALISED OEDEMA 34 0.0027
576 ORGAN FAILURE 11 0.0027
577 DIARRHOEA 1750 0.0027
578 HAEMORRHAGE 280 0.0027
579 SKIN INFECTION 30 0.0027
580 AORTIC DISSECTION 11 0.0027
581 THERAPY NON-RESPONDER 119 0.0026
582 RENAL DISORDER 123 0.0026
583 ASTHENIA 978 0.0026
584 GINGIVITIS 14 0.0026
585 FRACTURE 49 0.0026
586 ATRIOVENTRICULAR BLOCK 20 0.0026
587 DECUBITUS ULCER 21 0.0026
588 HYDROCEPHALUS 14 0.0026
589 ACUTE MYELOID LEUKAEMIA 40 0.0026
590 LUNG INFECTION 39 0.0025
591 GENERAL PHYSICAL CONDITION ABNORMAL 17 0.0025
592 ORAL CANDIDIASIS 33 0.0025
593 SPINAL OSTEOARTHRITIS 22 0.0025
594 HEPATITIS CHOLESTATIC 15 0.0025
595 DIABETES MELLITUS 189 0.0025
596 STATUS EPILEPTICUS 28 0.0025
597 RHINITIS ALLERGIC 11 0.0025
598 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
599 ARTHRITIS 193 0.0025
600 ASPHYXIA 20 0.0024
601 BLOOD SODIUM DECREASED 46 0.0024
602 MUSCULAR WEAKNESS 276 0.0024
603 DELIRIUM 84 0.0024
604 ILL-DEFINED DISORDER 147 0.0024
605 INTESTINAL OBSTRUCTION 91 0.0024
606 SECOND PRIMARY MALIGNANCY 20 0.0024
607 EMPHYSEMA 24 0.0024
608 TOXIC ENCEPHALOPATHY 12 0.0024
609 DIARRHOEA HAEMORRHAGIC 22 0.0024
610 DEHYDRATION 313 0.0023
611 PROCTALGIA 15 0.0023
612 HEPATIC CANCER 56 0.0023
613 ABDOMINAL PAIN 539 0.0023
614 TASTE DISORDER 47 0.0023
615 OEDEMA PERIPHERAL 281 0.0023
616 HYPOVOLAEMIC SHOCK 11 0.0023
617 PARTIAL SEIZURES 12 0.0023
618 WOUND INFECTION 25 0.0023
619 RASH 994 0.0023
620 ATAXIA 27 0.0023
621 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
622 EYELID PTOSIS 23 0.0023
623 APPENDICITIS 21 0.0022
624 NEUTROPHIL COUNT INCREASED 23 0.0022
625 HYPERVOLAEMIA 11 0.0022
626 EOSINOPHILIA 39 0.0022
627 PANCREATITIS ACUTE 50 0.0022
628 BLOOD UREA INCREASED 37 0.0022
629 BACTERIAL INFECTION 41 0.0022
630 MYOCARDIAL ISCHAEMIA 25 0.0022
631 ANAPHYLACTIC REACTION 121 0.0022
632 URINARY TRACT INFECTION 372 0.0022
633 ATRIAL FIBRILLATION 212 0.0022
634 HYPERTENSIVE CRISIS 24 0.0022
635 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
636 RENAL CYST 17 0.0021
637 CEREBRAL ISCHAEMIA 11 0.0021
638 LIVER FUNCTION TEST ABNORMAL 62 0.0021
639 CANDIDA INFECTION 36 0.0021
640 DIVERTICULITIS 59 0.0021
641 DYSPHAGIA 201 0.0021
642 SINUS TACHYCARDIA 30 0.0021
643 ASPIRATION 23 0.0021
644 PRODUCTIVE COUGH 100 0.0021
645 ESCHERICHIA INFECTION 17 0.0021
646 NO ADVERSE EVENT 373 0.0021
647 HYPERTRIGLYCERIDAEMIA 12 0.0020
648 DEEP VEIN THROMBOSIS 133 0.0020
649 ORAL DISORDER 15 0.0020
650 SQUAMOUS CELL CARCINOMA 19 0.0020
651 DUODENAL ULCER PERFORATION 15 0.0020
652 RHABDOMYOLYSIS 84 0.0020
653 GINGIVAL PAIN 16 0.0020
654 APHONIA 28 0.0020
655 FATIGUE 1560 0.0020
656 PLATELET COUNT ABNORMAL 12 0.0020
657 ASPERGILLUS INFECTION 13 0.0020
658 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
659 CELLULITIS 99 0.0020
660 DRUG RESISTANCE 50 0.0019
661 INFECTION 281 0.0019
662 RESPIRATORY DISORDER 58 0.0019
663 PERONEAL NERVE PALSY 11 0.0019
664 PHARYNGITIS 24 0.0019
665 CLOSTRIDIUM DIFFICILE INFECTION 42 0.0019
666 FEEDING DISORDER 39 0.0019
667 HEPATIC ENZYME INCREASED 131 0.0019
668 FLANK PAIN 18 0.0019
669 TACHYPNOEA 26 0.0019
670 HAEMOGLOBIN DECREASED 196 0.0019
671 HEPATITIS C 23 0.0019
672 COVID-19 332 0.0019
673 SPINAL PAIN 22 0.0019
674 MALNUTRITION 21 0.0019
675 DYSPNOEA 1061 0.0019
676 MYELODYSPLASTIC SYNDROME 27 0.0019
677 RECTAL HAEMORRHAGE 79 0.0018
678 HEPATOMEGALY 18 0.0018
679 RENAL FAILURE 242 0.0018
680 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
681 APPETITE DISORDER 12 0.0018
682 MUSCULOSKELETAL CHEST PAIN 28 0.0018
683 DYSPHONIA 105 0.0018
684 PULMONARY OEDEMA 80 0.0018
685 TYPE 2 DIABETES MELLITUS 60 0.0018
686 OXYGEN SATURATION DECREASED 100 0.0018
687 FISTULA 20 0.0018
688 UPPER RESPIRATORY TRACT INFECTION 82 0.0018
689 VOMITING 833 0.0018
690 SUBARACHNOID HAEMORRHAGE 18 0.0018
691 RESPIRATORY DISTRESS 48 0.0017
692 ALOPECIA 341 0.0017
693 INFLAMMATION 89 0.0017
694 HEMIPARESIS 29 0.0017
695 URINARY RETENTION 57 0.0017
696 LUNG INFILTRATION 15 0.0017
697 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
698 HYPOTENSION 335 0.0017
699 SEIZURE 192 0.0017
700 OSTEONECROSIS OF JAW 41 0.0017
701 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86 0.0016
702 BRONCHIECTASIS 11 0.0016
703 BRAIN NEOPLASM 15 0.0016
704 VIRAL INFECTION 54 0.0016
705 BONE PAIN 95 0.0016
706 COUGH 454 0.0016
707 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
708 RHINITIS 13 0.0016
709 FULL BLOOD COUNT ABNORMAL 17 0.0016
710 HYPOPHAGIA 41 0.0016
711 KETOACIDOSIS 12 0.0016
712 CARDIOGENIC SHOCK 23 0.0016
713 SPINAL FRACTURE 32 0.0016
714 GAIT INABILITY 53 0.0016
715 MOTOR DYSFUNCTION 16 0.0016
716 HAEMOLYSIS 12 0.0016
717 BLOOD POTASSIUM INCREASED 25 0.0015
718 EPILEPSY 47 0.0015
719 SHOCK 35 0.0015
720 IRON DEFICIENCY ANAEMIA 14 0.0015
721 CARDIAC ARREST 124 0.0015
722 COAGULOPATHY 25 0.0015
723 NEPHROPATHY 14 0.0015
724 BLOOD TEST ABNORMAL 21 0.0015
725 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 82 0.0015
726 ARTERIOSCLEROSIS 14 0.0015
727 HAEMORRHOIDS 29 0.0015
728 WEIGHT DECREASED 415 0.0015
729 CHILLS 173 0.0015
730 IMMUNODEFICIENCY 22 0.0015
731 BRONCHOSPASM 21 0.0015
732 SARS-COV-2 TEST POSITIVE 19 0.0014
733 CARDIO-RESPIRATORY ARREST 60 0.0014
734 RED BLOOD CELL COUNT DECREASED 41 0.0014
735 MASS 20 0.0014
736 TRANSIENT ISCHAEMIC ATTACK 48 0.0014
737 HYPOGLYCAEMIA 69 0.0014
738 DEVICE OCCLUSION 20 0.0014
739 CARDIOVASCULAR DISORDER 36 0.0014
740 HAEMATOCHEZIA 78 0.0014
741 PRURITUS 540 0.0014
742 MENTAL STATUS CHANGES 39 0.0014
743 MYALGIA 238 0.0014
744 DIPLOPIA 36 0.0014
745 DYSURIA 51 0.0014
746 ORAL PAIN 31 0.0014
747 NAUSEA 1095 0.0014
748 IMPAIRED HEALING 45 0.0014
749 ANKYLOSING SPONDYLITIS 18 0.0014
750 DYSPNOEA EXERTIONAL 51 0.0014
751 FOLLICULITIS 14 0.0013
752 SYNCOPE 132 0.0013
753 CONFUSIONAL STATE 213 0.0013
754 HIDRADENITIS 12 0.0013
755 CHEST PAIN 243 0.0013
756 THROMBOSIS 105 0.0013
757 DEAFNESS 34 0.0013
758 CONJUNCTIVITIS 24 0.0013
759 ANGINA PECTORIS 37 0.0013
760 CYSTITIS 41 0.0013
761 ABDOMINAL DISTENSION 134 0.0013
762 BACK PAIN 298 0.0013
763 BODY TEMPERATURE INCREASED 26 0.0013
764 DERMATITIS ALLERGIC 16 0.0013
765 ARRHYTHMIA 60 0.0013
766 NAIL DISORDER 11 0.0013
767 ULCER 20 0.0013
768 REBOUND EFFECT 14 0.0012
769 NODULE 16 0.0012
770 CEREBROVASCULAR ACCIDENT 206 0.0012
771 RENAL INJURY 36 0.0012
772 GASTROINTESTINAL DISORDER 108 0.0012
773 TACHYCARDIA 106 0.0012
774 HERPES ZOSTER 68 0.0012
775 VENTRICULAR FIBRILLATION 13 0.0012
776 EAR DISCOMFORT 12 0.0012
777 RIB FRACTURE 24 0.0012
778 MUSCULOSKELETAL PAIN 61 0.0012
779 OSTEOMYELITIS 21 0.0012
780 BLOOD CALCIUM DECREASED 13 0.0012
781 NIGHT SWEATS 37 0.0011
782 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
783 EAR PAIN 22 0.0011
784 ABSCESS 18 0.0011
785 FACE OEDEMA 19 0.0011
786 PARALYSIS 16 0.0011
787 DRY MOUTH 90 0.0011
788 ECZEMA 58 0.0011
789 BRAIN INJURY 11 0.0011
790 ADVERSE EVENT 100 0.0011
791 CYANOSIS 17 0.0011
792 LETHARGY 62 0.0011
793 COMA 50 0.0010
794 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
795 ORTHOSTATIC HYPOTENSION 18 0.0010
796 APHASIA 31 0.0010
797 DYSGEUSIA 76 0.0010
798 ARTHRALGIA 425 0.0010
799 MYOCARDIAL INFARCTION 178 0.0010
800 FEELING COLD 28 0.0010
801 CHRONIC KIDNEY DISEASE 76 0.0010
802 MUSCULOSKELETAL DISORDER 19 0.0010
803 CIRCULATORY COLLAPSE 17 0.0010
804 BLOOD POTASSIUM DECREASED 30 0.0010
805 INCORRECT PRODUCT STORAGE 13 0.0010
806 EATING DISORDER 21 0.0010
807 MALAISE 428 0.0010
808 HAEMATOMA 25 0.0010
809 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
810 BLOOD PRESSURE DECREASED 63 0.0009
811 COGNITIVE DISORDER 44 0.0009
812 ABDOMINAL PAIN UPPER 189 0.0009
813 PULMONARY HYPERTENSION 19 0.0009
814 SKIN LESION 25 0.0009
815 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
816 PRESYNCOPE 22 0.0009
817 FEMUR FRACTURE 28 0.0009
818 PSORIASIS 118 0.0009
819 HIP FRACTURE 29 0.0009
820 COLITIS ULCERATIVE 40 0.0009
821 INFLUENZA LIKE ILLNESS 73 0.0009
822 DISEASE RECURRENCE 42 0.0009
823 BONE DISORDER 16 0.0009
824 MUSCLE ATROPHY 11 0.0009
825 PRODUCT STORAGE ERROR 76 0.0009
826 KIDNEY INFECTION 17 0.0009
827 HYPOAESTHESIA 127 0.0008
828 LYMPHOMA 13 0.0008
829 TOOTH INFECTION 11 0.0008
830 FAECES DISCOLOURED 18 0.0008
831 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
832 BRONCHITIS 60 0.0008
833 PROSTATIC SPECIFIC ANTIGEN INCREASED 11 0.0008
834 PHOTOSENSITIVITY REACTION 13 0.0008
835 NEURALGIA 19 0.0008
836 GAIT DISTURBANCE 148 0.0008
837 PELVIC PAIN 14 0.0008
838 HYPERSENSITIVITY 143 0.0008
839 SUBDURAL HAEMATOMA 11 0.0008
840 CHOLELITHIASIS 25 0.0008
841 VERTIGO 46 0.0008
842 ERYTHEMA 154 0.0007
843 DRY SKIN 100 0.0007
844 SENSORY DISTURBANCE 12 0.0007
845 DISORIENTATION 29 0.0007
846 GLAUCOMA 14 0.0007
847 DRUG INTOLERANCE 69 0.0007
848 ABDOMINAL PAIN LOWER 18 0.0007
849 OROPHARYNGEAL PAIN 65 0.0007
850 HEPATIC STEATOSIS 13 0.0007
851 NECK PAIN 39 0.0007
852 CORONARY ARTERY DISEASE 21 0.0007
853 PRODUCT USE IN UNAPPROVED INDICATION 171 0.0007
854 LOSS OF CONSCIOUSNESS 88 0.0007
855 PRODUCT PREPARATION ERROR 14 0.0007
856 BRADYCARDIA 36 0.0007
857 HOT FLUSH 51 0.0007
858 GOUT 12 0.0007
859 DYSARTHRIA 25 0.0007
860 FALL 221 0.0007
861 TOOTHACHE 12 0.0007
862 RESTLESSNESS 24 0.0007
863 HAEMATOCRIT DECREASED 13 0.0007
864 MOVEMENT DISORDER 21 0.0007
865 HYPOACUSIS 28 0.0006
866 BLOOD PRESSURE INCREASED 99 0.0006
867 PAIN IN EXTREMITY 190 0.0006
868 AGEUSIA 16 0.0006
869 STAPHYLOCOCCAL INFECTION 21 0.0006
870 PAIN 389 0.0006
871 DYSPEPSIA 62 0.0006
872 RASH PRURITIC 34 0.0006
873 METABOLIC ACIDOSIS 20 0.0006
874 TOXICITY TO VARIOUS AGENTS 104 0.0006
875 RESPIRATORY ARREST 17 0.0006
876 DYSSTASIA 18 0.0006
877 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
878 CHEST DISCOMFORT 63 0.0006
879 SPEECH DISORDER 32 0.0006
880 URINARY INCONTINENCE 18 0.0006
881 RASH ERYTHEMATOUS 29 0.0006
882 FUNGAL INFECTION 20 0.0006
883 CARDIAC FAILURE CONGESTIVE 48 0.0006
884 CONDITION AGGRAVATED 180 0.0006
885 CARDIAC DISORDER 55 0.0006
886 CATARACT 35 0.0006
887 PARAESTHESIA 91 0.0006
888 HEADACHE 362 0.0006
889 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
890 HEART RATE IRREGULAR 13 0.0006
891 DEMENTIA 16 0.0006
892 BALANCE DISORDER 49 0.0006
893 DIZZINESS 282 0.0006
894 DRY EYE 28 0.0006
895 FLUSHING 57 0.0006
896 ILLNESS 57 0.0006
897 LIMB INJURY 15 0.0006
898 BLISTER 31 0.0006
899 DRUG INEFFECTIVE 715 0.0005
900 UNRESPONSIVE TO STIMULI 14 0.0005
901 INSOMNIA 143 0.0005
902 POLLAKIURIA 22 0.0005
903 FREQUENT BOWEL MOVEMENTS 14 0.0005
904 SWELLING 48 0.0005
905 PERIPHERAL SWELLING 79 0.0005
906 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
907 TREATMENT FAILURE 41 0.0005
908 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
909 RASH PAPULAR 11 0.0005
910 TINNITUS 22 0.0005
911 SKIN EXFOLIATION 40 0.0005
912 PROCEDURAL PAIN 13 0.0005
913 WHEEZING 27 0.0005
914 LOCALISED INFECTION 11 0.0005
915 INFLUENZA 50 0.0004
916 OSTEOARTHRITIS 19 0.0004
917 SOMNOLENCE 90 0.0004
918 FLATULENCE 25 0.0004
919 OSTEONECROSIS 14 0.0004
920 PAIN IN JAW 12 0.0004
921 LIMB DISCOMFORT 13 0.0004
922 PALLOR 11 0.0004
923 URTICARIA 67 0.0004
924 EYE DISORDER 13 0.0004
925 HEART RATE INCREASED 39 0.0004
926 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
927 MUSCLE SPASMS 71 0.0004
928 ANXIETY 110 0.0004
929 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
930 HEAD INJURY 12 0.0004
931 MOBILITY DECREASED 27 0.0004
932 LACTIC ACIDOSIS 12 0.0004
933 WEIGHT INCREASED 82 0.0004
934 DEPRESSION 83 0.0004
935 CONTUSION 35 0.0004
936 RHEUMATOID ARTHRITIS 41 0.0004
937 ARTHROPATHY 20 0.0004
938 NASOPHARYNGITIS 66 0.0004
939 MEMORY IMPAIRMENT 49 0.0004
940 TREMOR 59 0.0004
941 FLUID RETENTION 18 0.0004
942 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
943 THERAPEUTIC RESPONSE DECREASED 21 0.0003
944 PSORIATIC ARTHROPATHY 14 0.0003
945 VISION BLURRED 47 0.0003
946 SLEEP DISORDER 24 0.0003
947 VISUAL IMPAIRMENT 42 0.0003
948 BLOOD GLUCOSE DECREASED 16 0.0003
949 PALPITATIONS 39 0.0003
950 AMNESIA 21 0.0003
951 MENTAL DISORDER 14 0.0003
952 HALLUCINATION 24 0.0003
953 DISTURBANCE IN ATTENTION 17 0.0003
954 SINUSITIS 32 0.0003
955 ABDOMINAL DISCOMFORT 52 0.0003
956 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
957 SURGERY 18 0.0003
958 NASAL CONGESTION 18 0.0003
959 NEPHROLITHIASIS 14 0.0003
960 UNEVALUABLE EVENT 22 0.0003
961 ADVERSE DRUG REACTION 26 0.0003
962 HYPERHIDROSIS 36 0.0003
963 DISCOMFORT 17 0.0003
964 FEELING HOT 17 0.0003
965 SWELLING FACE 18 0.0003
966 ASTHMA 31 0.0003
967 THERAPY CESSATION 14 0.0003
968 BLOOD GLUCOSE INCREASED 51 0.0003
969 BLINDNESS 11 0.0003
970 BREAST CANCER 25 0.0003
971 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
972 ROAD TRAFFIC ACCIDENT 11 0.0003
973 BLADDER CANCER 15 0.0003
974 MUSCULOSKELETAL STIFFNESS 22 0.0003
975 NERVOUSNESS 13 0.0002
976 RHINORRHOEA 16 0.0002
977 SKIN DISCOLOURATION 11 0.0002
978 PRODUCT USE ISSUE 44 0.0002
979 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
980 MEDICATION ERROR 12 0.0002
981 AGITATION 15 0.0002
982 MIGRAINE 17 0.0002
983 DRUG INTERACTION 28 0.0002
984 UNDERDOSE 12 0.0002
985 JOINT SWELLING 19 0.0002
986 PROSTATE CANCER 12 0.0001
987 OVERDOSE 28 0.0001
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
989 FEELING ABNORMAL 26 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
991 PRODUCT DOSE OMISSION ISSUE 13 0.0000